Table 1.
Associations between infant cytomegalovirus PCR results at 24 weeks of age and infant morbidity/mortality and growth outcomes during 48 weeks of follow-up [The Breastfeeding, Antiretrovirals and Nutrition (BAN) Study, Lilongwe, Malawi].
| CMV PCR at 24 weeks
|
||
|---|---|---|
| Hazard ratio (95% CI)a | P value | |
| HIV infection (2–48 weeks) | 1.99 (0.57–6.92) | 0.28 |
| HIV infection (24–48 weeks) | 4.52 (0.58–35.3) | 0.15 |
| Infant death | 4.05 (0.51–32.0) | 0.18 |
| HIV infection or infant death (2–48 weeks) | 2.49 (0.86–7.21) | 0.09 |
| HIV infection or infant death (24–48 weeks) | 4.27 (0.99–18.4) | 0.05 |
| Severe pneumonia/SFI | 1.31 (0.78–2.18) | 0.31 |
| Severe diarrhea or growth faltering | 0.79 (0.38–1.66) | 0.54 |
| Severe malaria | 1.51 (0.47–4.84) | 0.49 |
|
| ||
| Mean difference in Z-score (95% CI)a | P value | |
|
| ||
| Weight-for-age | 0.02 (−0.17–0.22) | 0.81 |
| Length-for-age | 0.11 (−0.08–0.29) | 0.27 |
CI, confidence interval; CMV, cytomegalovirus; SFI, serious febrile illness.
a
All hazard ratios and coefficients adjusted for antiretroviral treatment group.